Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis
- 4 July 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 335 (1), 16-20
- https://doi.org/10.1056/nejm199607043350103
Abstract
Respiratory tract infections may trigger relapses in patients with Wegener's granu-lomatosis in remission. Uncontrolled data have suggested that treatment with trimethoprim–sulfamethoxazole (co-trimoxazole) may be beneficial.Keywords
This publication has 26 references indexed in Scilit:
- Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener GranulomatosisAnnals of Internal Medicine, 1994
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Association between active Wegener's granulomatosis and anticytoplasmic antibodiesArchives of Internal Medicine, 1989
- Anticytoplasmic Autoantibodies in the Diagnosis and Follow-Up of Wegener's GranulomatosisMayo Clinic Proceedings, 1989
- Infectious complications of cyclophosphamide treatment for vasculitisArthritis & Rheumatism, 1989
- Cyclophosphamide‐induced bladder toxicity in wegener's granulomatosisArthritis & Rheumatism, 1988
- PROSPECTIVE STUDY OF RADIOIMMUNOASSAY FOR ANTIBODIES AGAINST NEUTROPHIL CYTOPLASM IN DIAGNOSIS OF SYSTEMIC VASCULITISThe Lancet, 1987
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 YearsAnnals of Internal Medicine, 1983
- Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)BMJ, 1958